These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 31760222

  • 1. Oligonucleotide-functionalized hydrogels for sustained release of small molecule (aptamer) therapeutics.
    Agrawal NK, Allen P, Song YH, Wachs RA, Du Y, Ellington AD, Schmidt CE.
    Acta Biomater; 2020 Jan 15; 102():315-325. PubMed ID: 31760222
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Aptamer-functionalized hydrogel as effective anti-cancer drugs delivery agents.
    Wang Z, Xia J, Cai F, Zhang F, Yang M, Bi S, Gui R, Li Y, Xia Y.
    Colloids Surf B Biointerfaces; 2015 Oct 01; 134():40-6. PubMed ID: 26142627
    [Abstract] [Full Text] [Related]

  • 4. Programmable release of multiple protein drugs from aptamer-functionalized hydrogels via nucleic acid hybridization.
    Battig MR, Soontornworajit B, Wang Y.
    J Am Chem Soc; 2012 Aug 01; 134(30):12410-3. PubMed ID: 22816442
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dual Aptamer-Functionalized in Situ Injectable Fibrin Hydrogel for Promotion of Angiogenesis via Codelivery of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor-BB.
    Zhao N, Suzuki A, Zhang X, Shi P, Abune L, Coyne J, Jia H, Xiong N, Zhang G, Wang Y.
    ACS Appl Mater Interfaces; 2019 May 22; 11(20):18123-18132. PubMed ID: 31026135
    [Abstract] [Full Text] [Related]

  • 8. The enhancement of cell adherence and inducement of neurite outgrowth of dorsal root ganglia co-cultured with hyaluronic acid hydrogels modified with Nogo-66 receptor antagonist in vitro.
    Hou S, Tian W, Xu Q, Cui F, Zhang J, Lu Q, Zhao C.
    Neuroscience; 2006 May 22; 137(2):519-29. PubMed ID: 16298084
    [Abstract] [Full Text] [Related]

  • 9. Hyaluronic acid-based nanocomposite hydrogels for ocular drug delivery applications.
    Widjaja LK, Bora M, Chan PN, Lipik V, Wong TT, Venkatraman SS.
    J Biomed Mater Res A; 2014 Sep 22; 102(9):3056-65. PubMed ID: 24124098
    [Abstract] [Full Text] [Related]

  • 10. Stimuli-responsive releasing of gold nanoparticles and liposomes from aptamer-functionalized hydrogels.
    El-Hamed F, Dave N, Liu J.
    Nanotechnology; 2011 Dec 09; 22(49):494011. PubMed ID: 22101647
    [Abstract] [Full Text] [Related]

  • 11. In vitro sustained release of bioactive anti-NogoA, a molecule in clinical development for treatment of spinal cord injury.
    Stanwick JC, Baumann MD, Shoichet MS.
    Int J Pharm; 2012 Apr 15; 426(1-2):284-290. PubMed ID: 22306041
    [Abstract] [Full Text] [Related]

  • 12. DNA-crosslinked alginate and layered microspheres to modulate the release of encapsulated FITC-dextran.
    Turner D, Baldwin E, Russell K, Wells LA.
    Eur J Pharm Biopharm; 2021 Jan 15; 158():313-322. PubMed ID: 33259898
    [Abstract] [Full Text] [Related]

  • 13. A self-assembling peptide hydrogel-based drug co-delivery platform to improve tissue repair after ischemia-reperfusion injury.
    Liu S, Zhao M, Zhou Y, Li L, Wang C, Yuan Y, Li L, Liao G, Bresette W, Chen Y, Cheng J, Lu Y, Liu J.
    Acta Biomater; 2020 Feb 15; 103():102-114. PubMed ID: 31843715
    [Abstract] [Full Text] [Related]

  • 14. Sulfated hyaluronic acid hydrogels with retarded degradation and enhanced growth factor retention promote hMSC chondrogenesis and articular cartilage integrity with reduced hypertrophy.
    Feng Q, Lin S, Zhang K, Dong C, Wu T, Huang H, Yan X, Zhang L, Li G, Bian L.
    Acta Biomater; 2017 Apr 15; 53():329-342. PubMed ID: 28193542
    [Abstract] [Full Text] [Related]

  • 15. Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injury.
    Baumann MD, Kang CE, Tator CH, Shoichet MS.
    Biomaterials; 2010 Oct 15; 31(30):7631-9. PubMed ID: 20656347
    [Abstract] [Full Text] [Related]

  • 16. In situ chemically crosslinked injectable hydrogels for the subcutaneous delivery of trastuzumab to treat breast cancer.
    Lo YW, Sheu MT, Chiang WH, Chiu YL, Tu CM, Wang WY, Wu MH, Wang YC, Lu M, Ho HO.
    Acta Biomater; 2019 Mar 01; 86():280-290. PubMed ID: 30616077
    [Abstract] [Full Text] [Related]

  • 17. Sustained Release of Cx43 Antisense Oligodeoxynucleotides from Coated Collagen Scaffolds Promotes Wound Healing.
    Gilmartin DJ, Soon A, Thrasivoulou C, Phillips AR, Jayasinghe SN, Becker DL.
    Adv Healthc Mater; 2016 Jul 01; 5(14):1786-99. PubMed ID: 27253638
    [Abstract] [Full Text] [Related]

  • 18. Aptamer-Functionalized Bioscaffold Enhances Cartilage Repair by Improving Stem Cell Recruitment in Osteochondral Defects of Rabbit Knees.
    Wang X, Song X, Li T, Chen J, Cheng G, Yang L, Chen C.
    Am J Sports Med; 2019 Aug 01; 47(10):2316-2326. PubMed ID: 31233332
    [Abstract] [Full Text] [Related]

  • 19. Double Controlled Release of Therapeutic RNA Modules through Injectable DNA-RNA Hybrid Hydrogel.
    Han S, Park Y, Kim H, Nam H, Ko O, Lee JB.
    ACS Appl Mater Interfaces; 2020 Dec 16; 12(50):55554-55563. PubMed ID: 33259200
    [Abstract] [Full Text] [Related]

  • 20. Hyaluronic Acid-PEG-Based Diels-Alder In Situ Forming Hydrogels for Sustained Intraocular Delivery of Bevacizumab.
    Ilochonwu BC, Mihajlovic M, Maas-Bakker RF, Rousou C, Tang M, Chen M, Hennink WE, Vermonden T.
    Biomacromolecules; 2022 Jul 11; 23(7):2914-2929. PubMed ID: 35735135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.